Difference between revisions of "Fibronectin (Interaction partner)"
m |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | | | align="center" colspan="2" bgcolor="#ffffff" | | ||
Line 52: | Line 52: | ||
| | | | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Tissue transglutaminase interaction partners|*]] | [[Category:Tissue transglutaminase interaction partners|*]] |
Latest revision as of 12:16, 10 March 2015
Fibronectin (Interaction partner) | |
---|---|
Substrate peptide name | Fibronectin |
Synonyms | - |
Determination type | In situ |
Source | Homo sapiens |
Subcellular localization | Extracellular matrix |
Swissprot ID | P02751 |
Interacting residues | |
Interacting sequence | |
TG2 Swissprot ID | P21980 |
Interacting residues of TG2 | Asp94, Asp97 |
Interacting sequence of TG2 | TATVVDQQDCTLSL |
Structure | 1O6A |
Surface accessibility | |
Disorder prediction | IUPred |
Reference | PMID:15849356 |
Notes | |